86 results
Page 3 of 5
6-K
EX-99.1
fv1l1mtzrp6
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.1
prw18tpwsow4
13 Oct 20
Current report (foreign)
6:15am
6-K
EX-99.1
uus8 xtdazp1
28 Sep 20
Current report (foreign)
6:00am
6-K
EX-99.2
ti1ka4pxaqt2v07l
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
ke2490jg2js6u7ub5z2
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.1
20ysr18
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
056m azs8gzwa5h7oh
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.2
fm0xstgvkyq
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
gysrdsw7
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.1
ljmkyaupny
12 Nov 19
Current report (foreign)
6:15am
6-K
EX-99.2
4rg9i1uex
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.1
nwr1so
11 Oct 19
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks In Finch 1 and Finch 3 Studies In Rheumatoid Arthritis
6:00am
6-K
EX-99.2
vjkd3f5y
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
vy4ng5
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
xbhaj8z1j g5ia
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.1
zd0 g9es5c
11 Jun 19
Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
6:05am
6-K
EX-99.2
l5a cn5rbj9
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm